Self-Monitoring of Carbon Monoxide to Enhance Reproductive Outcomes in Women
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02246114|
Recruitment Status : Terminated (Lack of Recruitment)
First Posted : September 22, 2014
Results First Posted : January 16, 2017
Last Update Posted : January 16, 2017
|Condition or disease||Intervention/treatment||Phase|
|Pregnancy Smoking Smoking Cessation||Device: piCO+ Smokerlyzer® monitor Other: Text messages||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||1 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Self-Monitoring of Carbon Monoxide to Enhance Reproductive Outcomes in Women|
|Study Start Date :||September 2014|
|Actual Primary Completion Date :||May 2015|
|Actual Study Completion Date :||May 2015|
Experimental: no CO monitor
Not given a piCO+ Smokerlyzer® monitor, will receive daily text messages.
Other: Text messages
Experimental: CO monitor
Given a piCO+ Smokerlyzer® monitor, will receive daily text messages, will receive feedback about the relative level of carbon monoxide.
Device: piCO+ Smokerlyzer® monitor
Other: Text messages
- Primary Outcome of Serum Cotinine Levels [ Time Frame: 1 year ]The primary outcome is the difference in serum cotinine levels between the intervention and control groups at the end of the trial.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02246114
|United States, Pennsylvania|
|MS Hershey Medical Center, Penn State College of Medicine|
|Hershey, Pennsylvania, United States, 17033|
|Principal Investigator:||Richard S Legro, MD||Penn State College of Medicine|